Michael Belson

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters

Mark Dybul, Tae‐Wook Chun, Christian Yoder et al. · Proceedings of the National Academy of Sciences · 2001 · 156 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Long‐Cycle Structured Intermittent versus Continuous Highly Active Antiretroviral Therapy for the Treatment of Chronic Infection with Human Immunodeficiency Virus: Effects on Drug Toxicity and on Immunologic and Virologic Parameters

Mark Dybul, Elizabeth Nies‐Kraske, Marybeth Daucher et al. · The Journal of Infectious Diseases · 2003 · 83 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali

Bocar Baya, Chad J. Achenbach, Bourahima Kone et al. · International Journal of Infectious Diseases · 2019 · 83 citations · Full text

Public Health, Infectious Disease Control, Clinical Epidemiology +14

Pilot Study of the Effects of Intermittent Interleukin‐2 on Human Immunodeficiency Virus (HIV)–Specific Immune Responses in Patients Treated during Recently Acquired HIV Infection

Mark Dybul, Bertha Hidalgo, Tae‐Wook Chun et al. · The Journal of Infectious Diseases · 2002 · 81 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy

Mark Dybul, Marybeth Daucher, Mark A. Jensen et al. · Journal of Virology · 2003 · 46 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +16